• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症进展的免疫预测因子。

Immune predictors of cancer progression.

机构信息

Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, #04-06 Immunos, Biopolis, Singapore.

出版信息

Immunol Res. 2012 Sep;53(1-3):229-34. doi: 10.1007/s12026-012-8288-4.

DOI:10.1007/s12026-012-8288-4
PMID:22407576
Abstract

The immune system has multiple, complex, and sometimes opposing roles during cancer progression. While immune-compromised individuals have a higher incidence of cancers, inflammation is also associated with increased risk of disease progression. It is becoming apparent that simple measures of immune responses in the blood are of limited use in cancer. Instead, the importance of the exact identity and functional characteristics of tumor-infiltrating immune cells is increasingly recognized. This realization has led to recent studies that have revealed a critical role for chemokine expression in the tumor microenvironment and suggested a therapeutic potential of manipulating intratumoral expression of chemokines to alter the local immune milieu.

摘要

免疫系统在癌症进展过程中具有多种复杂且有时相互矛盾的作用。虽然免疫功能低下的个体癌症发病率较高,但炎症也与疾病进展风险增加有关。现在越来越明显的是,血液中免疫反应的简单测量在癌症中的用途有限。相反,肿瘤浸润免疫细胞的确切身份和功能特征的重要性越来越受到重视。这种认识导致了最近的研究,这些研究揭示了趋化因子表达在肿瘤微环境中的关键作用,并表明操纵趋化因子在肿瘤内的表达以改变局部免疫微环境具有治疗潜力。

相似文献

1
Immune predictors of cancer progression.癌症进展的免疫预测因子。
Immunol Res. 2012 Sep;53(1-3):229-34. doi: 10.1007/s12026-012-8288-4.
2
Chemokines and the immune response to cancer.趋化因子与癌症的免疫反应。
Immunity. 2021 May 11;54(5):859-874. doi: 10.1016/j.immuni.2021.01.012. Epub 2021 Apr 10.
3
The role of chemokines in cancer immune surveillance by the adaptive immune system.趋化因子在适应性免疫系统进行癌症免疫监视中的作用。
Semin Cancer Biol. 2009 Apr;19(2):76-83. doi: 10.1016/j.semcancer.2008.10.011. Epub 2008 Nov 7.
4
Emerging role of mTOR in tumor immune contexture: Impact on chemokine-related immune cells migration.mTOR 在肿瘤免疫微环境中的新作用:对趋化因子相关免疫细胞迁移的影响。
Theranostics. 2020 May 15;10(14):6231-6244. doi: 10.7150/thno.45219. eCollection 2020.
5
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.癌症微环境中的趋化因子及其在癌症免疫治疗中的相关性。
Nat Rev Immunol. 2017 Sep;17(9):559-572. doi: 10.1038/nri.2017.49. Epub 2017 May 30.
6
Emerging microRNAs in cancer diagnosis, progression, and immune surveillance.癌症诊断、进展和免疫监测中的新兴 microRNAs。
Cancer Lett. 2018 Dec 1;438:126-132. doi: 10.1016/j.canlet.2018.09.019. Epub 2018 Sep 17.
7
Natural immunity to cancer in humans.人类对癌症的天然免疫力。
Curr Opin Immunol. 2010 Apr;22(2):215-22. doi: 10.1016/j.coi.2010.02.006. Epub 2010 Mar 6.
8
Chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment.趋化因子在癌症发展和进展中的作用及其作为癌症治疗靶点分子的潜力。
Mediators Inflamm. 2014;2014:170381. doi: 10.1155/2014/170381. Epub 2014 May 22.
9
The inhibitory role of b7-h4 in antitumor immunity: association with cancer progression and survival.b7-h4在抗肿瘤免疫中的抑制作用:与癌症进展和生存的关联。
Clin Dev Immunol. 2011;2011:695834. doi: 10.1155/2011/695834. Epub 2011 Oct 13.
10
The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses.趋化因子 CXCL14 在癌症进展和免疫反应中的多样角色。
Mol Carcinog. 2020 Jul;59(7):794-806. doi: 10.1002/mc.23188. Epub 2020 Mar 24.

引用本文的文献

1
GTSE1: A potential prognostic and diagnostic biomarker in various tumors including lung adenocarcinoma.GTSE1:一种在多种肿瘤中具有潜在预后和诊断价值的生物标志物,包括肺腺癌。
Clin Respir J. 2024 May;18(5):e13757. doi: 10.1111/crj.13757.
2
Development and characterization of mammary intraductal (MIND) spontaneous metastasis models for triple-negative breast cancer in syngeneic mice.同源小鼠乳腺管内(MIND)自发转移模型的建立及其用于三阴性乳腺癌的特征描述。
Sci Rep. 2020 Mar 13;10(1):4681. doi: 10.1038/s41598-020-61679-8.
3
Cancer-driven dynamics of immune cells in a microfluidic environment.

本文引用的文献

1
How to develop better screens for anti-cancer therapies?如何开发更好的抗癌疗法筛选工具?
Oncoimmunology. 2012 May 1;1(3):383-384. doi: 10.4161/onci.18805.
2
Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor.间质转化和癌细胞的扩散是由浸润原发性肿瘤的髓系来源抑制细胞驱动的。
PLoS Biol. 2011 Sep;9(9):e1001162. doi: 10.1371/journal.pbio.1001162. Epub 2011 Sep 27.
3
Chemotherapy induces intratumoral expression of chemokines in cutaneous melanoma, favoring T-cell infiltration and tumor control.
微流控环境中癌症驱动的免疫细胞动态变化
Sci Rep. 2014 Oct 16;4:6639. doi: 10.1038/srep06639.
4
Development and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progression.乳腺癌肺微小转移至巨转移进展的临床前模型的建立与鉴定。
PLoS One. 2014 May 30;9(5):e98624. doi: 10.1371/journal.pone.0098624. eCollection 2014.
5
ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis.ADAM8 在浸润性乳腺癌中的表达促进肿瘤的扩散和转移。
EMBO Mol Med. 2014 Feb;6(2):278-94. doi: 10.1002/emmm.201303373. Epub 2013 Dec 27.
6
Myelopoietic efficacy of orlistat in murine hosts bearing T cell lymphoma: implication in macrophage differentiation and activation.载脂蛋白抑制剂奥利司他在 T 细胞淋巴瘤荷瘤鼠中的骨髓造血疗效:对巨噬细胞分化和激活的影响。
PLoS One. 2013 Dec 3;8(12):e82396. doi: 10.1371/journal.pone.0082396. eCollection 2013.
7
FOXP3 subcellular localization predicts recurrence in oral squamous cell carcinoma.FOXP3 亚细胞定位可预测口腔鳞状细胞癌的复发。
PLoS One. 2013 Aug 20;8(8):e71908. doi: 10.1371/journal.pone.0071908. eCollection 2013.
8
The tumor microenvironment: a pitch for multiple players.肿瘤微环境:多方参与的舞台。
Front Oncol. 2013 Apr 17;3:90. doi: 10.3389/fonc.2013.00090. eCollection 2013.
化疗诱导皮肤黑色素瘤肿瘤内趋化因子的表达,有利于 T 细胞浸润和肿瘤控制。
Cancer Res. 2011 Nov 15;71(22):6997-7009. doi: 10.1158/0008-5472.CAN-11-1466. Epub 2011 Sep 26.
4
Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma.趋化因子驱动的淋巴细胞浸润:决定可切除肝细胞癌长期生存的早期肿瘤内事件。
Gut. 2012 Mar;61(3):427-38. doi: 10.1136/gutjnl-2011-300509. Epub 2011 Sep 19.
5
Dacarbazine promotes stromal remodeling and lymphocyte infiltration in cutaneous melanoma lesions.达卡巴嗪促进皮肤黑色素瘤病变中的基质重构和淋巴细胞浸润。
J Invest Dermatol. 2011 Sep;131(9):1896-905. doi: 10.1038/jid.2011.128. Epub 2011 Jun 9.
6
Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis.主动监测与初始治疗比较用于低危前列腺癌患者:决策分析。
JAMA. 2010 Dec 1;304(21):2373-80. doi: 10.1001/jama.2010.1720.
7
Human papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epithelium.人乳头瘤病毒 16 型相关的宫颈上皮内瘤变在人类中可使 CD8+T 细胞排除于发育不良的上皮之外。
J Immunol. 2010 Dec 1;185(11):7107-14. doi: 10.4049/jimmunol.1002756. Epub 2010 Oct 29.
8
Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma.在黑色素瘤的小鼠模型中,肿瘤细胞早期就会扩散,但免疫监视限制了转移的生长。
J Clin Invest. 2010 Jun;120(6):2030-9. doi: 10.1172/JCI42002. Epub 2010 May 24.
9
Myeloid-derived suppressor cell heterogeneity and subset definition.髓系来源抑制性细胞异质性及其亚群定义。
Curr Opin Immunol. 2010 Apr;22(2):238-44. doi: 10.1016/j.coi.2010.01.021. Epub 2010 Feb 17.
10
Screening, prevention and treatment of cervical cancer -- a global and regional generalized cost-effectiveness analysis.宫颈癌的筛查、预防与治疗——一项全球及区域综合成本效益分析
Vaccine. 2009 Oct 9;27(43):6060-79. doi: 10.1016/j.vaccine.2009.07.026. Epub 2009 Jul 31.